Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States
The field of innate immune target-mediated activation has experienced a dynamic year, with both promising clinical data on the horizon and recent setbacks on the minds of drug developers. In light of these developments, it is an ideal time to bring together the community to discuss the current state of the industry and consider next steps.
The 4th STING AND TLR Targeting Therapies Summit will bring together over 100 leading figures in the field of innate targeting therapies, representing large pharmaceutical companies, biotech firms, and academia. This event will provide a unique opportunity to explore the various STING AND TLR agonists in development, review clinical trial data, learn from high-profile failures, evaluate delivery approaches, and discuss strategies to optimize clinical trials and accelerate your innate agonist pipelines.
The Symposium on Artificial Intelligence for Learning Health Systems (SAIL) is an annual international conference launched in 2020 to explore the integration of artificial intelligence (AI) techniques into clinical medicine. SAIL, which will next be held in Puerto Rico in 2023, provides a forum for clinicians, clinical informaticians and AI researchers to discuss approaches and challenges to using these approaches in the healthcare domain. Researchers from the fields of clinical informatics and machine learning have been concerned for decades with bridging the gap between quantitative research and clinical practice. Less appreciated, perhaps, is a potential disconnect between the communities of clinical informatics and machine learning researchers themselves. Clinical informaticians, for their part, have unique experience integrating their tools within hospital IT systems, and working with administrators, privacy policies, and quality improvement officers. Computer scientists, for their part, have frequently spearheaded the development of novel methodological tools and high-performance computing. Both of these research communities seek to work effectively with clinicians, who provide important domain expertise and interaction with patients. One explicit goal of this conference is to foster the translation of AI to the clinic by catalyzing collaborations that leverage the strengths of all three of these communities. A second goal is to facilitate discussion among diverse stakeholders- the three communities described above as well as funders and decision makers around the non-technical barriers to better care through AI. The inaugural Program Committee of SAIL was led by Jessie Tenenbaum (Duke), Jason Moore (UPenn), Nicholas Tatonetti (Columbia), Suchi Saria (Johns Hopkins), and Isaac Kohane (Harvard).
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our